JPMorgan analyst James Gordon raised the firm’s price target on Argenx to EUR 480 from EUR 470 and keeps an Overweight rating on the shares.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARGX:
- argenx to Present at Upcoming Investor Conferences
- Jefferies pharma/biopharma analysts hold analyst/industry conference call
- Cowen biotech/pharma analysts hold an analyst/industry conference call
- Argenx price target raised to $440 from $425 at H.C. Wainwright
- Piper Sandler remains a buyer of Argenx after Q3 beat
